Presentations

Rodman & Renshaw November 2008 Presentation

News Highlights

June 30, 2009
Maxygen Announces Joint Venture with Astellas to Develop Protein Pharmaceuticals

May 11, 2009
Maxygen Reports First Quarter 2009 Financial Results

May 7, 2009
Maxygen Announces MAXY-G34 Licensing Arrangement with Cangene for Acute Radiation Syndrome

May 7, 2009
Maxygen First Quarter 2009 Financial Results Conference Call Notice

February 10, 2009
Maxygen Reports Fourth Quarter and Year End 2008 Financial Results